Reuters: FDA warns of fetal risk with transplant drugs

[NaDiNe]

FDA warns of fetal risk with transplant drugs
      

WASHINGTON (Reuters) - U.S. health officials issued an alert on Friday warning about the risk of miscarriages and birth defects with transplant drugs sold by Novartis AG and Roche Holding AG.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login